These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 15147434

  • 1. fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: post-hoc subgroup analyses of the ALERT Study.
    Jardine AG, Holdaas H, Fellström B, Cole E, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Maes B, Ambühl P, Olsson AG, Holme I, Fauchald P, Gimpelwicz C, Pedersen TR, ALERT Study Investigators.
    Am J Transplant; 2004 Jun; 4(6):988-95. PubMed ID: 15147434
    [Abstract] [Full Text] [Related]

  • 2. Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial.
    Holdaas H, Fellström B, Jardine AG, Holme I, Nyberg G, Fauchald P, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Olsson AG, Hartmann A, Solbu DO, Pedersen TR, Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators.
    Lancet; 2003 Jun 14; 361(9374):2024-31. PubMed ID: 12814712
    [Abstract] [Full Text] [Related]

  • 3. Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus: a randomized placebo-controlled study.
    Norby GE, Holme I, Fellström B, Jardine A, Cole E, Abedini S, Holdaas H, Assessment of Lescol in Renal Transplantation Study Group.
    Arthritis Rheum; 2009 Apr 14; 60(4):1060-4. PubMed ID: 19333947
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation.
    Holdaas H, Fellström B, Jardine AG, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Logan JO, Staffler B, Gimpelewicz C, ALERT Study Group.
    Nephrol Dial Transplant; 2005 May 14; 20(5):974-80. PubMed ID: 15784644
    [Abstract] [Full Text] [Related]

  • 7. Fluvastatin reduces the impact of diabetes on long-term outcome after coronary intervention--a Lescol Intervention Prevention Study (LIPS) substudy.
    Arampatzis CA, Goedhart D, Serruys PW, Saia F, Lemos PA, de Feyter P, LIPS Investigators.
    Am Heart J; 2005 Feb 14; 149(2):329-35. PubMed ID: 15846273
    [Abstract] [Full Text] [Related]

  • 8. No detrimental effect on renal function during long-term use of fluvastatin in renal transplant recipients in the Assessment of Lescol in Renal Transplantation (ALERT) study.
    Fellström B, Abedini S, Holdaas H, Jardine AG, Staffler B, Gimpelewicz C, Assessment of Lescol in Renal Transplantation (ALERT) study group.
    Clin Transplant; 2006 Feb 14; 20(6):732-9. PubMed ID: 17100723
    [Abstract] [Full Text] [Related]

  • 9. Impact of fluvastatin on hyperlipidemia after renal transplantation.
    Tokumoto T, Tanabe K, Ishida H, Shimmura H, Ishikawa N, Goya N, Akiba T, Toma H.
    Transplant Proc; 2004 Sep 14; 36(7):2141-4. PubMed ID: 15518777
    [Abstract] [Full Text] [Related]

  • 10. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV).
    Dunkelgrun M, Boersma E, Schouten O, Koopman-van Gemert AW, van Poorten F, Bax JJ, Thomson IR, Poldermans D, Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group.
    Ann Surg; 2009 Jun 14; 249(6):921-6. PubMed ID: 19474688
    [Abstract] [Full Text] [Related]

  • 11. Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial.
    Liem AH, van Boven AJ, Veeger NJ, Withagen AJ, Robles de Medina RM, Tijssen JG, van Veldhuisen DJ, FLuvastatin On Risk Diminishment after Acute myocardial infarction study group.
    Eur Heart J; 2002 Dec 14; 23(24):1931-7. PubMed ID: 12473255
    [Abstract] [Full Text] [Related]

  • 12. A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial.
    Serruys PW, Foley DP, Jackson G, Bonnier H, Macaya C, Vrolix M, Branzi A, Shepherd J, Suryapranata H, de Feyter PJ, Melkert R, van Es GA, Pfister PJ.
    Eur Heart J; 1999 Jan 14; 20(1):58-69. PubMed ID: 10075142
    [Abstract] [Full Text] [Related]

  • 13. Effect of fluvastatin on lipoprotein profiles in treating renal transplant recipients with dyslipoproteinemia.
    Li PK, Mak TW, Chan TH, Wang A, Lam CW, Lai KN.
    Transplantation; 1995 Oct 15; 60(7):652-6. PubMed ID: 7570971
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fluvastatin and low-density lipoprotein oxidation in hypercholesterolemic renal transplant patients.
    Martínez-Castelao A, Grinyó JM, Fiol C, Castiñeiras MJ, Hurtado I, Gil-Vernet S, Serón D, Porta I, Miñarro A, Villarroya A, Alsina J.
    Kidney Int Suppl; 1999 Jul 15; 71():S231-4. PubMed ID: 10412785
    [Abstract] [Full Text] [Related]

  • 16. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial.
    Serruys PW, de Feyter P, Macaya C, Kokott N, Puel J, Vrolix M, Branzi A, Bertolami MC, Jackson G, Strauss B, Meier B, Lescol Intervention Prevention Study (LIPS) Investigators.
    JAMA; 2002 Jun 26; 287(24):3215-22. PubMed ID: 12076217
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Renal transplant dysfunction--importance quantified in comparison with traditional risk factors for cardiovascular disease and mortality.
    Soveri I, Holdaas H, Jardine A, Gimpelewicz C, Staffler B, Fellström B.
    Nephrol Dial Transplant; 2006 Aug 26; 21(8):2282-9. PubMed ID: 16574686
    [Abstract] [Full Text] [Related]

  • 20. Risk factors for reaching renal endpoints in the assessment of Lescol in renal transplantation (ALERT) trial.
    Fellström B, Holdaas H, Jardine AG, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Olsson AG, Staffler B, Pedersen TR, Assessment of Lescol in Renal Transplantation Study Investigators.
    Transplantation; 2005 Jan 27; 79(2):205-12. PubMed ID: 15665769
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.